Wyatt R J, Julian B A, Baehler R W, Stafford C C, McMorrow R G, Ferguson T, Jackson E, Woodford S Y, Miller P M, Kritchevsky S
Department of Pediatrics, University of Tennessee and Crippled Children's Foundation Research Center, Memphis 38103, USA.
J Am Soc Nephrol. 1998 May;9(5):853-8. doi: 10.1681/ASN.V95853.
Population-based incidence data for IgA nephropathy (IgAN) are available for some countries but not for the United States. The purpose of this study was to determine the incidence of IgAN in central and eastern Kentucky for 5- and 10-yr periods between 1975 and 1994 and to examine differences among patient groups between those periods. The incidence of IgAN was 5.4 cases per one million population per year (MPPY) for period 1A (1975 through 1979), increasing to 12.4 cases per MPPY for period 2B (1990 through 1994) (P < 0.001). Males had a 2.7 times higher incidence than females for period 1 (1975 through 1984) and 2.2 times higher for period 2 (1985 through 1994). For period 1A, the incidence for Fayette County, which includes the city of Lexington, was lower than that of the rest of the study area (P=0.26), whereas for period 2 the incidence was higher for Fayette County (P=0.052). During period 1, the highest incidence of IgAN for any age and gender group was 24.3 cases per MPPY for males ages 30 through 39. For period 2, the incidence for males was similar for each decade between ages 20 and 59 (approximately 19 cases per MPPY). No African-American was diagnosed during period 1, but in period 2 incidences for blacks and whites were similar (10.7 and 10.2 cases per MPPY, respectively). For the last 5 yr of the study (1990 through 1994), the incidence of end-stage renal disease (ESRD) due to IgAN was 5.5 cases per MPPY: 8.4 for males and 2.7 for females. The incidence of IgAN in Kentucky for period 2B was still much lower than that in European studies, but the incidence of ESRD due to IgAN may be similar. Thus, IgAN may be as important a condition with respect to ESRD in Kentucky as it is in other regions of the world.
一些国家有基于人群的IgA肾病(IgAN)发病率数据,但美国没有。本研究的目的是确定1975年至1994年期间肯塔基州中部和东部5年及10年的IgAN发病率,并研究这两个时期不同患者群体之间的差异。1A期(1975年至1979年)IgAN的发病率为每年每百万人口5.4例(MPPY),到2B期(1990年至1994年)增至每MPPY 12.4例(P < 0.001)。第1期(1975年至1984年)男性发病率比女性高2.7倍,第2期(1985年至1994年)高2.2倍。对于1A期,包括列克星敦市的费耶特县的发病率低于研究区域的其他地区(P = 0.26),而在第2期,费耶特县的发病率较高(P = 0.052)。在第1期,任何年龄和性别的组中IgAN的最高发病率是30至39岁男性的每MPPY 24.3例。在第2期,20至59岁之间每个十年男性的发病率相似(约每MPPY 19例)。第1期没有非裔美国人被诊断出患有该病,但在第2期,黑人和白人的发病率相似(分别为每MPPY 10.7例和10.2例)。在研究的最后5年(1990年至1994年),因IgAN导致的终末期肾病(ESRD)发病率为每MPPY 5.5例:男性为8.4例,女性为2.7例。肯塔基州2B期IgAN的发病率仍远低于欧洲研究中的发病率,但因IgAN导致的ESRD发病率可能相似。因此,在肯塔基州,IgAN对于ESRD而言可能与世界其他地区一样重要。